Effect of Unani Formulation and ibubrofen in the treatment of Osteoarthritis
- Registration Number
- CTRI/2010/091/000585
- Lead Sponsor
- Central council for research in Unani medicine-CCRUM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 60
Aged between 40 to 70 years
Either Sex
Patients diagnosed according to American College of Rheumatology Criteria for osteoarthritis of different joints will be selected
Patients with symptoms consistent with osteoarthritis of the joint involved for at least six months prior to screening.
Patients, who will be willing to discontinue all NSAIDs or other analgesic medication taken for any condition, will be included in the test group.
Willingness to sign the informed consent, follow the protocol and participate in clinical trial voluntarily.
Pregnancy and Lactation
Diabetes mellitus
Renal dysfunction
Liver diseases
Gastrointestinal diseases(Peptic ulcer disease)
Other types of arthritis
IHD and hypertension
History of surgery of the joint involved
Patients who will be unable to read/or understand the WOMAC questionnaire form
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method